Sagar Lonial
Director/Board Member chez TG THERAPEUTICS, INC.
Fortune : 2 M $ au 31/03/2024
Profil
Sagar Lonial is currently an Independent Director at TG Therapeutics, Inc. He is also the Department Chair-Hematology & Medical Oncology at Emory University School of Medicine and the Chief Medical Officer at Winship Cancer Institute.
Dr. Lonial obtained a doctorate degree from the University of Louisville School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
TG THERAPEUTICS, INC.
0,07% | 13/03/2024 | 108 878 ( 0,07% ) | 2 M $ | 31/03/2024 |
Postes actifs de Sagar Lonial
| Sociétés | Poste | Début |
|---|---|---|
| TG THERAPEUTICS, INC. | Director/Board Member | 29/04/2020 |
| Winship Cancer Institute | Chief Tech/Sci/R&D Officer | - |
| Emory University School of Medicine | Corporate Officer/Principal | - |
Formation de Sagar Lonial
| University of Louisville School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TG THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
| Winship Cancer Institute |
